Dopamine and Norepinephrine Reuptake Inhibitor Market

Key Players

• Novartis International AG
• Mylan N.V.
• Pfizer Inc.
• Eli Lilly and Company
• GlaxoSmothKline plc
• Merck & AND companies IS NULL; Co.
• AbbVie Inc
• Teva Pharmaceuticals
• Bristol Myers Squibb Company
• Alkermes plc